A5055579589- Acute Ischemic Stroke Management
- Traditional Chinese Medicine Analysis
- Stroke Rehabilitation and Recovery
- Retinal and Optic Conditions
- Neurological Disease Mechanisms and Treatments
- Plant-based Medicinal Research
- Venous Thromboembolism Diagnosis and Management
- Intracerebral and Subarachnoid Hemorrhage Research
Affiliated Hospital of Nantong University
2025
Nantong University
2025
Hainan 301 Hospital
2023
Weatherford College
2021
Committee on Publication Ethics
2021
BACKGROUND: Whether it is effective and safe to extend the time window of intravenous thrombolysis up 24 hours after last known well unknown. We aimed determine efficacy safety tenecteplase in Chinese patients with acute ischemic stroke due large/medium vessel occlusion within an extended window. METHODS: Patients presenting 4.5 from well, a favorable penumbral profile associated occlusion, were randomized 1:1 either 0.25 mg/kg or best medical treatment. A was defined as hypoperfusion lesion...
Post-stroke depression (PSD) constitutes a significant complication that influences both patient survival and functional recovery following stroke. Despite its prevalence, PSD still lacks long-term, safe effective treatment measure. Remote ischemic conditioning (RIC) is simple noninvasive procedure exert neuroprotective effects. This pilot study aims to investigate the efficacy, safety, feasibility of RIC as preventive measure against PSD. Acute stroke patients within 15 days post-event were...
Second-generation catheters used in mechanical thrombectomy have different advantages and disadvantages. The objective of this study was to evaluate the effectiveness safety combination contact aspiration stent retriever technique on rate reperfusion after for large vessel occlusion. Patients who underwent alone (CAA cohort, n = 150), (SRA 129), or combined (CSR 122) techniques following were included analysis. A balloon guide catheter all thrombectomies. Digital subtraction angiography...
Acute ischemic stroke (AIS) is characterized by high disabling and recurrent recurrence, its severe neurological impairment vascular adverse events (AEs) limit the recovery of patients. Danhong injection a complementary alternative to treatment AIS, previous studies have demonstrated efficacy safety. However, there no long-term follow-up rigorous clinical study evaluate effect on AEs in patients with AIS.This prospective randomized, double-blind, placebo-controlled trial investigating AIS....